ASPE

FCP Mezzanine Publishes a Construction Specifications Institute (CSI) Specification for Their Modular Mezzanine System

Retrieved on: 
Tuesday, August 22, 2023
FCP, IBC, ASPE, International Building Code, Construction Specifications Institute, Free-space optical communication, Name, CBC, Spec, AISI, Society, CSI, Safety, Cargo, Warehouse

VENTURA, Calif., Aug. 22, 2023 /PRNewswire-PRWeb/ -- FCP Mezzanine, a leading manufacturer of industrial steel mezzanines, elevated work platforms, and related safety components, is pleased to announce the publication of their Construction Specifications Institute (CSI) spec document for modular mezzanines. Now building contractors, architects, and other construction industry professionals can easily incorporate FCP's proprietary Free-Space Mezzanine™ system into their designs and cost proposals.

Key Points: 
  • FCP Mezzanine announces their CSI Spec publication for their proprietary Free-Space Mezzanines™, a modular mezzanine structure featuring FCP's exclusive ConnectRite™ connection system.
  • VENTURA, Calif., Aug. 22, 2023 /PRNewswire-PRWeb/ -- FCP Mezzanine , a leading manufacturer of industrial steel mezzanines , elevated work platforms, and related safety components, is pleased to announce the publication of their Construction Specifications Institute (CSI) spec document for modular mezzanines .
  • Now building contractors, architects, and other construction industry professionals can easily incorporate FCP's proprietary Free-Space Mezzanine™ system into their designs and cost proposals.
  • The CSI Modular Mezzanine CSI Spec document is free to download and doesn't require any pre-signup or commitment.

Top Canada Pharmacy in 2023 Launches New Initiative to Make Drugs More Affordable for U.S. Patients

Retrieved on: 
Monday, March 6, 2023
Patient, ASPE, Pharmacy, Plasma protein binding, Pharmaceutical industry

VANCOUVER, BC, March 6, 2023 /PRNewswire/ -- SaveRxCanada.to, a leading and reliable Canada pharmacy intermediary is glad to announce the launch of a new initiative aimed at making drugs more affordable for U.S. patients. The company's new initiative will provide access to high-quality medications at 70% lower than U.S. pharmacies to individuals who are struggling to pay for their prescription medications.

Key Points: 
  • VANCOUVER, BC, March 6, 2023 /PRNewswire/ -- SaveRxCanada.to , a leading and reliable Canada pharmacy intermediary is glad to announce the launch of a new initiative aimed at making drugs more affordable for U.S. patients.
  • That's where Canada pharmacies can help U.S. patients find affordable prescription drugs.
  • During times of drug price inflation, customers can turn to SaveRxCanada.to's RxSelect program that helps U.S. and international patients find cheaper prescription drugs at more affordable costs.
  • Our main initiative is just one of the ways we're working to provide drugs at an affordable cost for U.S. patients.

Top Canadian Pharmacy in 2023 Helps Reduce Prescription Drug Costs in the U.S.

Retrieved on: 
Monday, February 20, 2023
Kaiser Family Foundation, ASPE, Pharmacy, Elijah Cummings Lower Drug Costs Now Act, Prescription, Kaiser, Patient, News, Pharmaceutical industry

VANCOUVER, BC, Feb. 20, 2023 /PRNewswire/ -- SaveRxCanada.to, a trusted Canadian pharmacy intermediary is committed to providing quality prescription drugs at prices that U.S. patients can afford. In a move to help reduce prescription drug costs, the company offers a more affordable option for high-quality medications.

Key Points: 
  • VANCOUVER, BC, Feb. 20, 2023 /PRNewswire/ -- SaveRxCanada.to , a trusted Canadian pharmacy intermediary is committed to providing quality prescription drugs at prices that U.S. patients can afford.
  • In a move to help reduce prescription drug costs, the company offers a more affordable option for high-quality medications.
  • SaveRxCanada.to says, "We understand that prescription drug costs can be a major barrier to accessing necessary healthcare.
  • In addition, the ASPE statistics show that during the same time period home healthcare prescription drug costs increased 95%.

Nearly half of Americans are or expect to soon be caregivers, but fewer than 20% are planning for their own long-term care

Retrieved on: 
Friday, November 18, 2022
Finance, Seniors, Consumer, Professional Services, Insurance, FTSE4Good Index, Molecular epidemiology, Bloomberg, Edmund S. Muskie Internship Program, ASPE, Parent, Consumer, Health, Grandparent, Long-term care, LNC, Multimedia, NYSE, Insurance, Death, Marketing, Research, Lincoln, Retirement, Physician, WayUp, Nursing home, Lincoln National Corporation, Optimism, Family, Corporate Equality Index, Risk, Live, Barrier, Dow Jones, LTCG, Health insurance, Medicine, Residential care, Management, Caregiver

Lincoln is offering three tips to help Americans make the most of these critical conversations:

Key Points: 
  • Lincoln is offering three tips to help Americans make the most of these critical conversations:
    Anyone could need long-term care support.
  • People tend to downplay their personal risk, often assuming others face a greater risk of needing care.
  • Americans also far underestimate the potential cost of long-term care, believing their savings will cover their needs.
  • I watched my own parents face numerous challenges providing care for my grandparents, at a point before long-term care insurance was well-known.

Laars® Heating Systems showcase premium water heating solutions at ASPE Expo

Retrieved on: 
Thursday, September 1, 2022
Booth, Bradford White, AHRI, Stainless steel, Solution, Hydronics, Society, Pennant, NOx, American Society of Plumbing Engineers, ASPE, Industry, Marketing, Heating, ventilation, and air conditioning, Video game, Expo, Mart Laar

ROCHESTER, N.H., Sept. 1, 2022 /PRNewswire/ -- Laars® Heating Systems, an industry-leading manufacturer of commercial, residential, and industrial water and space heating products, will showcase a selection of high-efficiency, innovative products at the American Society of Plumbing Engineers (ASPE) Convention & Expo in Indianapolis in September.

Key Points: 
  • "ASPE is one of the year's best opportunities to connect with the people who trust and rely on Laars products," said Chuck O'Donnell, director of marketing for Laars Heating Systems.
  • The two-day ASPE Expo (Sept. 19-20) is a unique opportunity to discover new plumbing technologies and practical solutions to plumbing design challenges directly from product experts.
  • Laars OmniTherm: The Laars OmniTherm boilers and volume water heaters are available in six sizes from 1250 to 3000 MBH, with stainless steel heat exchangers and Laars Linc intuitive controls.
  • LaarsHeating Systems, headquartered in Rochester, N.H., manufactures and distributes products widely used in residential and commercial space heating, radiant floor heating, volume water heating, and in industrial process markets.

Bradford White showcases premium water heating solutions at ASPE Expo

Retrieved on: 
Thursday, September 1, 2022
Booth, Modbus, BMS, Solution, HTD, Temperature, Society, Brute, American Society of Plumbing Engineers, BACnet, ASPE, Industry, Marketing, Bradford, Bradford White, Heating, ventilation, and air conditioning, Kerosene, Expo

AMBLER, Pa., Sept. 1, 2022 /PRNewswire/ -- Bradford White Water Heaters, an industry-leading manufacturer of water heaters, boilers and storage tanks, will showcase a selection of high-performing, innovative products at the American Society of Plumbing Engineers (ASPE) Convention & Expo in Indianapolis in September.

Key Points: 
  • "As one of the preeminent events for our industry, ASPE provides an important opportunity for our experts to connect with our customers who rely on Bradford White products," said Carl Pinto, Jr., senior director of marketing communications for Bradford White.
  • The two-day ASPE Expo (Sept. 19-20) is a unique opportunity to discover new plumbing technologies and practical solutions to plumbing design challenges directly from product experts.
  • During the Expo, information and demonstrations will be available for the following trusted Bradford White products:
    ElectriFLEX Series: Bradford White ElectriFLEX Series field convertible commercial electric water heaters deliver a fast, reliable solution for commercial customers.
  • Bradford White Water Heaters is a full-line manufacturer of residential, commercial and industrial water heating, space heating, combination heating and storage products.

Improving Water Quality in Today's Modern Hygiene Infrastructure on Tap at Seventh Annual Emerging Water Technology Symposium

Retrieved on: 
Friday, May 20, 2022
ASPE, Black Belt (region of Alabama), Risk, History, American Society of Plumbing Engineers, DeMarco, Certification, High-Potential Management Personnel Reserve, IAPMO, Sanitation, SAWS, Solution, Water.org, Oakridge Centre, International, Sanitation Standard Operating Procedures, Society, Plumbing Manufacturers International, Water, SAN, Partnership, Water quality, Wildfire, PMI, Alliance for Water Efficiency, San Antonio Water System, AWE, International Association, Mechanical, Water efficiency, Legionella, CEO, Renewable energy, Plumbing, Management, Legionnaires' disease

SAN ANTONIO, May 20, 2022 /PRNewswire/ -- With the nation's largest federal investment in water underway in the form of the 2021 Infrastructure Investment and Jobs Act, water quality and water conservation solutions took center stage last week at the biennial Emerging Water Technology Symposium (EWTS).

Key Points: 
  • SAN ANTONIO, May 20, 2022 /PRNewswire/ -- With the nation's largest federal investment in water underway in the form of the 2021 Infrastructure Investment and Jobs Act, water quality and water conservation solutions took center stage last week at the biennial Emerging Water Technology Symposium (EWTS).
  • "In about 19 years, we've seen water and sanitation access reach more than 45 million people through more than 10 million microloans, with $3.7 billion disbursed to households," he said.
  • One development, the Oakridge Centre, utilized the IAPMO Water Demand Calculator and is expected to have the largest non-potable water system in North America.
  • Improved water management requires knowledgeable Legionella prevention and water service providers, which can come from certification to ASSE/IAPMO/ANSI 12080 for Legionella Water Safety and Management Personnel.

NRx Pharmaceuticals Announces Enrollment of First Patient in Phase II Study of Bipolar Depression with Sub-Acute Suicidality

Retrieved on: 
Thursday, May 12, 2022
ASPE, GSK, Lilly, Lists of diseases, Risk, Suicide, Regulation of tobacco by the U.S. Food and Drug Administration, Company, Food, US Foods, Letter, Hospital, Nasdaq, Suicidal ideation, Patient, Goal, Health, Lurasidone, United States Army, MPH, COVID-19, Bipolar disorder, Ketamine, National Security Advisor (United States), FDA, National, Breakthrough therapy, Dark Enlightenment, General officer, Substance abuse, Biotechnology, NMDA, Behavior, Private Securities Litigation Reform Act, ASIB, Support, Fast Track, Critical, Pharmaceutical industry, Life insurance, Teva, Pfizer, MD

NRx Pharmaceuticals, Inc., enrolled its first patient in one of two psychiatry studies being initiated this year; this first trial is studying patients with bipolar depression and sub-acute suicidality (not requiring hospitalization).

Key Points: 
  • NRx Pharmaceuticals, Inc., enrolled its first patient in one of two psychiatry studies being initiated this year; this first trial is studying patients with bipolar depression and sub-acute suicidality (not requiring hospitalization).
  • NRx Pharmaceuticals plans to start an NRX-101 Phase IIb/III registrational trial in patients with bipolar depression and acute suicidal ideation and behavior (ASIB) (requiring hospitalization) later this year.
  • In the second half of this year, NRx Pharmaceuticals expects to initiate a Phase IIb/III registrational trial in patients with bipolar depression and acute suicidal ideation and behavior (ASIB), which requires hospitalization of the patient.
  • NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) ("NRx Pharmaceuticals" or the "Company") draws upon decades of collective, scientific, and drug-development experience to bring improved health to patients.

NRx Pharmaceuticals to Report First Quarter 2022 Results on May 16, 2022

Retrieved on: 
Tuesday, May 10, 2022
COVID-19, Critical, National, ASPE, Nasdaq, Company, Biotechnology, Ketamine, Food, Lists of diseases, General officer, Patient, United States Army, Webcast, FDA, International, Earnings call, US Foods, Letter, ASIB, Lilly, Behavior, Fast Track, Breakthrough therapy, Health, Private Securities Litigation Reform Act, MPH, Conference, National Security Advisor (United States), GSK, ID, Goal, Support, Pharmaceutical industry, Pfizer, MD, Teva

RADNOR, Pa., May 10, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals"), a clinical-stage, biopharmaceutical company today announced that management will report first quarter 2022 financial results prior to the market open on May 16, 2022. The company will host a conference call and webcast on May 16, 2022, 8:30AM Eastern Time to discuss its results and provide a clinical and corporate update. Management will host the call, followed by a question-and-answer period. Investors interested in submitting questions must do so in advance of the call and are encouraged to email questions to the Company's investor relations representative at [email protected] by 4:00 PM Eastern Time on May 13, 2022.

Key Points: 
  • --Company to Host Conference Call May 16, 2022, at 8:30AM ET--
    RADNOR, Pa., May 10, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals"), a clinical-stage, biopharmaceutical company today announced that management will report first quarter 2022 financial results prior to the market open on May 16, 2022.
  • The company will host a conference call/webcast 5/16/22, @8:30 AM ET to discuss results and provide a corporate update.
  • NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) ("NRx Pharmaceuticals" or the "Company") draws upon decades of collective, scientific, and drug-development experience to bring improved health to patients.
  • This announcement of NRx Pharmaceuticals, Inc. includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the U.S.

NRx Pharmaceuticals Files New Breakthrough Therapy Designation Request for ZYESAMI® (aviptadil) in Subgroup of Patients with Critical COVID-19 with Respiratory Failure that were also treated with Remdesivir and continued to progress

Retrieved on: 
Thursday, April 21, 2022
Lilly, Biotechnology, Behavior, Breakthrough therapy, COVID-19, US Foods, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, National, Food, Private Securities Litigation Reform Act, GSK, Support, Patient, Goal, ASPE, Safety, Nasdaq, Company, General officer, Letter, ASIB, National Security Advisor (United States), Ketamine, Fast Track, FDA, Aviptadil, Health, Lists of diseases, United States Army, Survival, MPH, Pharmaceutical industry, Teva, Critical, MD, Pfizer

The request includes safety data on approximately 750 patients treated with intravenous ZYESAMI for Critical COVID-19.

Key Points: 
  • The request includes safety data on approximately 750 patients treated with intravenous ZYESAMI for Critical COVID-19.
  • NRx Pharmaceuticals submitted a Breakthrough Therapy designation request at the end of September 2021, which the FDA did not grant.
  • In February, NRx Pharmaceuticals submitted a new Emergency Use Authorization request also focused on this narrower patient population.
  • NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals" or the "Company") draws upon decades of collective, scientific, and drug-development experience to bring improved health to patients.